PCV20 for the prevention of invasive pneumococcal disease in the Mexican pediatric population: A cost-effectiveness analysis. [PDF]
Huerta JL +5 more
europepmc +1 more source
Burden of paediatric invasive pneumococcal disease in Europe, 2005 [PDF]
E. David G. McIntosh +2 more
openalex +1 more source
Antimicrobial activity of β-lactam antibiotics against pneumococcal isolates causing pneumococcal disease in adults immediately before and after the COVID-19 pandemic in Spain (2019-2020). [PDF]
Llamosí M +10 more
europepmc +1 more source
The rise of serotype 8 is associated with lineages and mutations in the capsular operon with different potential to produce invasive pneumococcal disease. [PDF]
Pérez-García C +9 more
europepmc +1 more source
Bacteraemia in homozygous sickle cell disease in Africa: is pneumococcal prophylaxis justified? [PDF]
Mark Kizito +3 more
openalex +1 more source
Epidemiological Impact of Increasing Vaccination Coverage Rate and Re-Vaccination on Pneumococcal Disease in Older Adults in Germany. [PDF]
Sharomi O +8 more
europepmc +1 more source
Increasing incidence of serotype 38 invasive pneumococcal disease driven by the ST393 clone among children, Denmark 2022-2024. [PDF]
Schjørring CB +6 more
europepmc +1 more source
A new approach to define the optimal immunization strategy against pneumococcal disease: the example of Canada. [PDF]
De Wals P.
europepmc +1 more source
Serotype 3 invasive pneumococcal disease in Tuscany across the eras of conjugate vaccines (2005-2024) and anthropic-driven respiratory virus fluctuations. [PDF]
Lodi L +15 more
europepmc +1 more source

